Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
On the basis of previous research, this subject intends to evaluate the liver improvement of patients with liver disease after weight loss by MRI, and quantify it by extracting features, so as to provide a new method to judge the liver status of patients with liver disease, and to evaluate the correlation between the inflammatory status of patients and the quantitative features of MRI, and try to explain the reasons for the improvement of fatty liver status of patients with liver disease after weight loss. To provide a new theoretical basis for fatty liver and systemic inflammatory liver damage in patients with liver disease after weight loss surgery, and to link them, and try to explain the improvement of fatty liver in patients with liver disease through the reduction of systemic inflammatory level.
This study is a prospective study to explore the improvement of fatty liver and severe state of the whole body in patients with liver disease undergoing weight-loss surgery. The research object is obese patients who underwent laparoscopic sleeve gastrectomy in our hospital. According to the standard of accepting the discharge, about 50 patients were selected and divided into groups according to preoperative, postoperative one month, postoperative three months and postoperative six months.All patients underwent routine sequence examinations using a Siemens 3.0T MRI scanner (MAGNETOM Prisma, Siemens Healthcare, Munich, Germany).This study investigates alterations in NAFLD among patients with obesity who underwent bariatric surgery using MRI-PDFF and MRS techniques. Additionally, we evaluated the factors that may influence these changes in patients after the surgical procedure.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Before operation, 1 month after operation, 3 months after operation and 6 months after operation. | Patients who underwent bariatric surgery were followed up regularly before and after surgery. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| We do not have any intervention type | Other | We do not have any intervention type |
|
| Measure | Description | Time Frame |
|---|---|---|
| Liver fat fraction | The primary outcome was a indicator for evaluating liver fat content. | before surgery、one 、three、six month after surgery |
| white blood cell | The primary outcome was a indicator for evaluating inflammation. | before surgery、one 、three、six month after surgery |
| aspartate aminotransferase | The primary outcome was a indicator for evaluating liver function. | before surgery、one 、three、six month after surgery |
| alanine aminotransferase | The primary outcome was a indicator for evaluating liver function. | before surgery、one 、three、six month after surgery |
| C-reactive protein | The primary outcome was a indicators for evaluating inflammation. | before surgery、one 、three、six month after surgery |
| neutrophile granulocyte | The primary outcome was a indicator for evaluating inflammation. | before surgery、one 、three、six month after surgery |
| Measure | Description | Time Frame |
|---|---|---|
| low-density lipoprotein | The secondary outcome was a indicator for evaluating blood fat. | before surgery、one 、three、six month after surgery |
| high-density lipoprotein | The secondary outcome was a indicator for evaluating blood lipid. |
| Measure | Description | Time Frame |
|---|---|---|
| Body Mass Index | The pre-specified outcome was a indicator for evaluating effectiveness of bariatric surgery. | before surgery、one 、three、six month after surgery |
Inclusion Criteria:
Exclusion criteria:
Not provided
Not provided
The major Study Population were who had accept the bariatric surgery.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| yu li, Dr | Contact | 18661809631 | liyu11920@hotmail.com | |
| xin li, Dr | Contact | 15065327781 |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Qingdao University Affiliated Hospital | Recruiting | Qingdao | Shandong | 266000 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D065626 | Non-alcoholic Fatty Liver Disease |
| ID | Term |
|---|---|
| D005234 | Fatty Liver |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| before surgery、one 、three、six month after surgery |
| glucose | The secondary outcome was a indicator for evaluating blood glucose. | before surgery、one 、three、six month after surgery |